Literature DB >> 1409626

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

D Lin1, M T Shields, S J Ullrich, E Appella, W E Mercer.   

Abstract

Conditional expression of wild-type (wt) p53 protein in a glioblastoma tumor cell line has been shown to be growth inhibitory. We have now more precisely localized the position in the cell cycle where growth arrest occurs. We show that growth arrest occurs prior to or near the restriction point in late G1 phase of the cell cycle. The effect of wt p53 protein on the expression of four immediate-early genes (c-FOS, c-JUN, JUN-B, and c-MYC), one delayed-early gene (ornithine decarboxylase), and two late-G1/S-phase genes (B-MYB and DNA polymerase alpha) was also examined. Of this subset of growth response genes, only the expression of B-MYB and DNA polymerase alpha was significantly repressed. The possibility that decreased expression of B-MYB may be an important component of growth arrest mediated by wt p53 protein is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409626      PMCID: PMC50095          DOI: 10.1073/pnas.89.19.9210

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.

Authors:  A M Gewirtz; G Anfossi; D Venturelli; S Valpreda; R Sims; B Calabretta
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

Review 2.  Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

Authors:  D Bohmann; T J Bos; A Admon; T Nishimura; P K Vogt; R Tjian
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

Review 3.  Protooncogene expression during the cell cycle.

Authors:  L Kaczmarek
Journal:  Lab Invest       Date:  1986-04       Impact factor: 5.662

4.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.

Authors:  A M Gewirtz; B Calabretta
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

5.  A gene activated by growth factors is related to the oncogene v-jun.

Authors:  K Ryder; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 6.  Molecules involved in proliferation of normal and cancer cells: presidential address.

Authors:  A B Pardee
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  Expression of thymidine kinase and dihydrofolate reductase genes in mammalian ts mutants of the cell cycle.

Authors:  H T Liu; C W Gibson; R R Hirschhorn; S Rittling; R Baserga; W E Mercer
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

9.  Correlation between cell cycle duration and RNA content.

Authors:  Z Darzynkiewicz; D P Evenson; L Staiano-Coico; T K Sharpless; M L Melamed
Journal:  J Cell Physiol       Date:  1979-09       Impact factor: 6.384

10.  Nucleotide sequence of cloned cDNA of human c-myc oncogene.

Authors:  R Watt; L W Stanton; K B Marcu; R C Gallo; C M Croce; G Rovera
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

View more
  58 in total

1.  Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.

Authors:  J Doherty; R Freund
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.

Authors:  S A Maxwell; G E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells.

Authors:  Attila Bacsi; G John Stanton; Thomas K Hughes; Marian Kruze; Istvan Boldogh
Journal:  Cell Mol Neurobiol       Date:  2005-11       Impact factor: 5.046

5.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.

Authors:  G S Firestein; K Nguyen; K R Aupperle; M Yeo; D L Boyle; N J Zvaifler
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.

Authors:  S N Jones; A T Sands; A R Hancock; H Vogel; L A Donehower; S P Linke; G M Wahl; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  A p53-independent damage-sensing mechanism that functions as a checkpoint at the G1/S transition in Chinese hamster ovary cells.

Authors:  H Lee; J M Larner; J L Hamlin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

8.  Cytoplasmic p53 polypeptide is associated with ribosomes.

Authors:  B M Fontoura; C A Atienza; E A Sorokina; T Morimoto; R B Carroll
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

9.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.

Authors:  L L Kelley; W F Green; G G Hicks; M C Bondurant; M J Koury; H E Ruley
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.